Hasil Pencarian - Sivakumar Vijayaraghavalu
Anda harus masuk terlebih dahulu
- Menampilkan 1 - 7 hasil dari 7
-
1
Emerging Strategies in Mesenchymal Stem Cell-Based Cardiovascular Therapeutics oleh Rishabh Kumar, Nitin Mishra, Talan Tran, Munish Kumar, Sivakumar Vijayaraghavalu, Narasimman Gurusamy
Diterbitkan 2024-05-01
Artikel -
2
-
3
Differential Expression of Non-Coding RNAs in Stem Cell Development and Therapeutics of Bone Disorders oleh Anurag Mishra, Rishabh Kumar, Satya Narayan Mishra, Sivakumar Vijayaraghavalu, Neeraj Kumar Tiwari, Girish C. Shukla, Narasimman Gurusamy, Munish Kumar
Diterbitkan 2023-04-01
Artikel -
4
Transferrin-Grafted Albumin Nanoparticles for the Targeted Delivery of Apocynin and Neuroprotection in an In Vitro Model of the BBB oleh Venkatesan Perumal, Arun Reddy Ravula, Agnieszka Agas, Manisha Kannan, Xiangshan Liu, Shanmuga Sundari I, Sivakumar Vijayaraghavalu, James Haorah, Yuanwei Zhang, Namas Chandra
Diterbitkan 2023-01-01
Artikel -
5
Enhanced Targeted Delivery of Minocycline via Transferrin Conjugated Albumin Nanoparticle Improves Neuroprotection in a Blast Traumatic Brain Injury Model oleh Venkatesan Perumal, Arun Reddy Ravula, Agnieszka Agas, Aakaash Gosain, Aswati Aravind, Ponnurengam Malliappan Sivakumar, Shanmuga Sundari I, Karthik Sambath, Sivakumar Vijayaraghavalu, Namas Chandra
Diterbitkan 2023-02-01
Artikel -
6
Author Correction: An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients oleh Rajan Ravichandran, Surapaneni Krishna Mohan, Suresh Kumar Sukumaran, Devakumar Kamaraj, Sumetha Suga Daivasuga, Samson Oliver Abraham Samuel Ravi, Sivakumar Vijayaraghavalu, Ramarathnam Krishna Kumar
Diterbitkan 2022-06-01
Artikel -
7
An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients oleh Rajan Ravichandran, Surapaneni Krishna Mohan, Suresh Kumar Sukumaran, Devakumar Kamaraj, Sumetha Suga Daivasuga, Samson Oliver Abraham Samuel Ravi, Sivakumar Vijayaraghavalu, Ramarathnam Krishna Kumar
Diterbitkan 2022-04-01
Artikel